Ischemia/reperfusion injury (IRI) permeates a variety of diseases and is a ubiquitous
concern in every transplantation proceeding, from whole organs to modest grafts. Given its …

Liver ischemia/reperfusion injury has been extensively studied during the last decades and
has been implicated in the pathophysiology of many clinical entities following hepatic …

Current management of liver ischemia-reperfusion (I/R) injury is mainly based on supportive
care and no specific treatment is available. Irisin, a recently identified hormone, plays pivotal …

Ischemia-reperfusion injury (IRI) is believed to contribute to graft dysfunction after liver
transplantation (LT). However, studies on IRI and the impact of early allograft dysfunction …

Ischemia-reperfusion injury (IRI) is the main cause of morbidity and mortality due to graft
rejection after liver transplantation. During IRI, an intense inflammatory process occurs in the …

Cytoprotective gene heme oxygenase 1 (HO-1) could be induced by nuclear factor E2-
related factor 2 (Nrf2) nuclear translocation. The purpose of this study was to determine the …

Acute liver injury (ALI) is a globally important public health issue that, when severe, rapidly
progresses to acute liver failure, seriously compromising the life safety of patients. The …

Liver ischemia‐reperfusion (I‐R) injury occurs during liver resection, liver transplantation,
and hemorrhagic shock. The main mode of liver cell death after warm and/or cold liver I‐R is …

Tea is a worldwide popular drink with high nutritional and medicinal values as it is rich in
nutrients, such as polyphenols, amino acids, vitamins, glycosides, and so on. Among them …

Ischemia/reperfusion (I/R) injury remains a major complication of liver resection,
transplantation, and hemorrhagic shock. Although the mechanisms that contribute to hepatic …